Transgene, a biotechnology company based in France, has successfully given a new immunotherapeutic drug to a first person in a Phase 1/2a clinical trial at St. James Hospital, Leeds. The trial tests the drug TG6002 on colorectal cancer patients with inoperable liver metastasis. At the Leeds trial, the new drug was delivered directly into the…
Details
Chemotherapy has been used extensively in the treatment of cancer for the past seventy years. It involves the use of toxic chemicals that kill rapidly dividing cells that build into a cancerous tumour. Unfortunately, classic chemotherapy not only destroys cancer cells but also healthy cells and can weaken or even destroy the patient’s immune system.…
Details
Illustration: Massachusetts General Hospital As we noted in our CAR T Cell Therapy blog, ( 6 November, 2019), there has been a surge in the understanding of how to activate the body’s immune system to combat cancer. The development and use of modified cells, known as chimeric antigen receptor CAR T Cells which have the…
Details
Our hair, its colour and style is a crucial part of our personal identity. Sudden hair loss is an acutely stressful part of chemotherapy. This hair loss is caused by taxanes, the anti-cancer drugs used in treatment. Such loss can have a psychologically depressing effect on all patients during therapy, particularly child and adult female…
Details